HUT77611A - Eljárás dózisegységek előállítására nedves granulálással - Google Patents

Eljárás dózisegységek előállítására nedves granulálással

Info

Publication number
HUT77611A
HUT77611A HU9800154A HU9800154A HUT77611A HU T77611 A HUT77611 A HU T77611A HU 9800154 A HU9800154 A HU 9800154A HU 9800154 A HU9800154 A HU 9800154A HU T77611 A HUT77611 A HU T77611A
Authority
HU
Hungary
Prior art keywords
pct
dosage units
wet granulation
date
sec
Prior art date
Application number
HU9800154A
Other languages
English (en)
Other versions
HU226619B1 (en
Inventor
Jocominus Antonius Maria Zwinkels
Pieter De Haan
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of HUT77611A publication Critical patent/HUT77611A/hu
Publication of HU226619B1 publication Critical patent/HU226619B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU9800154A 1994-09-22 1995-09-19 Process of making dosage units containing at least one progestogen by wet granulation HU226619B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94202728 1994-09-22
PCT/EP1995/003692 WO1996009056A1 (en) 1994-09-22 1995-09-19 Process of making dosage units by wet granulation

Publications (2)

Publication Number Publication Date
HUT77611A true HUT77611A (hu) 1998-06-29
HU226619B1 HU226619B1 (en) 2009-04-28

Family

ID=8217217

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9800154A HU226619B1 (en) 1994-09-22 1995-09-19 Process of making dosage units containing at least one progestogen by wet granulation

Country Status (22)

Country Link
US (1) US5916593A (hu)
EP (1) EP0782449B1 (hu)
JP (1) JP4334616B2 (hu)
KR (1) KR100384264B1 (hu)
CN (1) CN1101681C (hu)
AT (1) ATE236639T1 (hu)
AU (1) AU700645B2 (hu)
BR (1) BR9509019B1 (hu)
CA (1) CA2200754C (hu)
CZ (1) CZ289081B6 (hu)
DE (1) DE69530308T2 (hu)
DK (1) DK0782449T3 (hu)
ES (1) ES2196079T3 (hu)
FI (1) FI118791B (hu)
HU (1) HU226619B1 (hu)
MX (1) MX9702162A (hu)
NO (1) NO311492B1 (hu)
NZ (1) NZ293606A (hu)
PL (1) PL181406B1 (hu)
PT (1) PT782449E (hu)
RU (1) RU2166936C2 (hu)
WO (1) WO1996009056A1 (hu)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0955048A1 (en) * 1998-03-12 1999-11-10 Akzo Nobel N.V. Making dosage units using low shear granulation
IL128818A0 (en) * 1998-03-12 2000-01-31 Akzo Nobel Nv Making dosage units using low shear granulation
AU2669700A (en) * 1999-02-24 2000-09-14 Akzo Nobel N.V. Pharmaceutical compositions containing a crystalline form of the progestagen-(17alpha)-17-hydroxy-11-methylene-19-nor-pregna- 4,15-dien-20-yn-3-one (org 30659) and lactose
SI1598069T1 (sl) * 1999-08-31 2009-10-31 Bayer Schering Pharma Ag Farmacevtska kombinacija etinilestradiola in drospirenona za uporabo kot kontracepitev
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
EP1216713A1 (en) * 2000-12-20 2002-06-26 Schering Aktiengesellschaft Compositions of estrogen-cyclodextrin complexes
US20030027848A1 (en) * 2001-06-15 2003-02-06 Anne Billotte Stabilized formulations
ATE243028T1 (de) * 2001-07-11 2003-07-15 Applied Pharma Res Fettlösliche substanzen enthaltende granulate und verfahren zu ihrer herstellung
DE10159120B4 (de) * 2001-12-01 2006-08-17 Lts Lohmann Therapie-Systeme Ag Steroidhormonhaltige transdermale therapeutische Systeme enthaltend Propylenglycolmonocaprylat und seine Verwendung
GB0209265D0 (en) * 2002-04-23 2002-06-05 Novartis Ag Organic compounds
TW200403075A (en) * 2002-05-29 2004-03-01 Akzo Nobel Nv Progestagenic dosage units
SI1596870T2 (sl) 2002-12-20 2011-07-29 Hoffmann La Roche Formulacija z visokim odmerkom ibandronata
RU2228747C1 (ru) * 2003-03-03 2004-05-20 Открытое акционерное общество "Щелковский витаминный завод" Антиангинальное средство пролонгированного действия
CZ298224B6 (cs) * 2003-04-29 2007-07-25 Pliva Istrazivanje I Razvoj D.O.O. Farmaceutická kompozice obsahující jako úcinnou látku ribavirin a zpusob její výroby
WO2005030176A1 (en) 2003-09-29 2005-04-07 Novo Nordisk Femcare Ag Improved stability of progestogen formulations
WO2005030175A1 (en) * 2003-09-29 2005-04-07 Novo Nordisk Femcare Ag Hrt formulations
JP4412963B2 (ja) * 2003-10-10 2010-02-10 旭有機材工業株式会社 バルブ用樹脂製部材
WO2005097076A2 (en) * 2004-04-09 2005-10-20 Smithkline Beecham Corporation Low dose pharmaceutical products
US7846466B2 (en) * 2004-06-10 2010-12-07 Northwestern University Biodegradable scaffolds and uses thereof
EP1806149A4 (en) * 2004-10-25 2012-12-05 Japan Tobacco Inc SOLID MEDICINAL PREPARATION IMPROVED IN TERMS OF SOLUBILITY AND STABILITY AND METHOD FOR PRODUCING SAME
CN101128206A (zh) * 2005-01-21 2008-02-20 沃纳奇尔科特公司 固体剂型形式的四环素类金属络合物
CN101128189A (zh) 2005-02-25 2008-02-20 弗·哈夫曼-拉罗切有限公司 药物物质分散性改善的片剂
CN101489563A (zh) 2006-07-06 2009-07-22 拜耳先灵医药股份有限公司 用于避孕和预防先天性畸形风险的药物制剂
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
US20090269403A1 (en) * 2008-04-24 2009-10-29 Shaked Ze Ev Oral contraceptive dosage forms and methods of making such dosage forms
AU2009279521A1 (en) * 2008-08-08 2010-02-11 Mcneil-Ppc, Inc. Use of sucralose as a granulating agent
MX2011003731A (es) * 2008-10-09 2011-08-03 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Uso de solventes organicos en la granulacion humeda de moxifloxacino.
US8945616B2 (en) * 2009-02-17 2015-02-03 Mylan Pharmaceuticals Inc. Controlled release budesonide minitablets
US8945615B2 (en) * 2009-02-17 2015-02-03 Mylan Pharmaceuticals Inc. Controlled release budesonide minitablets
JP2017001989A (ja) * 2015-06-11 2017-01-05 ニプロ株式会社 医薬組成物の製造方法及び医薬組成物
JP6759478B2 (ja) * 2019-02-13 2020-09-23 富士製薬工業株式会社 経口固形組成物、その製造方法、及びその製造方法によって得られた経口用錠剤

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3969502A (en) * 1972-04-14 1976-07-13 Schering Aktiengesellschaft Method for contraception by the administration of sequential contraceptive preparations
GB2192128A (en) * 1986-07-03 1988-01-06 Fa Ez Khan Production of pharmaceutical unit dosage forms
US4956182A (en) * 1989-03-16 1990-09-11 Bristol-Myers Company Direct compression cholestyramine tablet and solvent-free coating therefor
US5200197A (en) * 1989-11-16 1993-04-06 Alza Corporation Contraceptive pill
US5098714A (en) * 1989-11-16 1992-03-24 Alza Corporation Osmotic, oral dosage form for fertility control
IE62665B1 (en) * 1990-12-17 1995-02-22 Akzo Nv Contraceptive regimen
IE71202B1 (en) * 1990-12-17 1997-02-12 Akzo Nv Progestagen-only contraceptive
IE67345B1 (en) * 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations
DE4229820C2 (de) * 1992-09-07 1998-12-03 Jenapharm Gmbh Pharmazeutische Zubereitung auf Gestagen-Basis
CA2151260A1 (en) * 1993-02-23 1994-09-01 Warner-Lambert Company A process for the preparation of substantially alcohol free pharmaceutical compositions
ATE180669T1 (de) * 1993-03-05 1999-06-15 Akzo Nobel Nv Verwendung von pregnanderivaten zur behandlung von tumoren
NL9301562A (nl) * 1993-09-09 1995-04-03 Saturnus Ag Preparaat voor substitutietherapie.
ZA939565B (en) * 1993-12-21 1994-08-11 Applied Analytical Ind Inc Method for preparing low dose pharmaceutical products.

Also Published As

Publication number Publication date
NZ293606A (en) 1998-06-26
CZ289081B6 (cs) 2001-10-17
PL319373A1 (en) 1997-08-04
US5916593A (en) 1999-06-29
NO971361L (no) 1997-05-21
DE69530308T2 (de) 2003-10-16
FI118791B (fi) 2008-03-31
KR100384264B1 (ko) 2003-08-30
CA2200754C (en) 2008-04-15
EP0782449A1 (en) 1997-07-09
PT782449E (pt) 2003-07-31
RU2166936C2 (ru) 2001-05-20
CN1101681C (zh) 2003-02-19
ES2196079T3 (es) 2003-12-16
NO311492B1 (no) 2001-12-03
ATE236639T1 (de) 2003-04-15
DE69530308D1 (de) 2003-05-15
WO1996009056A1 (en) 1996-03-28
CN1161650A (zh) 1997-10-08
AU700645B2 (en) 1999-01-14
NO971361D0 (no) 1997-03-21
BR9509019A (pt) 1997-12-30
HK1002172A1 (en) 1998-08-07
BR9509019B1 (pt) 2009-01-13
DK0782449T3 (da) 2003-08-04
JPH10505846A (ja) 1998-06-09
AU3608295A (en) 1996-04-09
CA2200754A1 (en) 1996-03-28
EP0782449B1 (en) 2003-04-09
HU226619B1 (en) 2009-04-28
KR970706001A (ko) 1997-11-03
PL181406B1 (pl) 2001-07-31
JP4334616B2 (ja) 2009-09-30
FI971172L (fi) 1997-03-20
FI971172A0 (fi) 1997-03-20
MX9702162A (es) 1997-06-28
CZ89997A3 (en) 1997-09-17

Similar Documents

Publication Publication Date Title
HUT77611A (hu) Eljárás dózisegységek előállítására nedves granulálással
IL116083A (en) Liquid pharmaceutical compositions containing ondanseteron and sorbitol as sweetener
ATE260646T1 (de) Schnell zerfallende orale dosierungsform
DK0758241T3 (da) Anvendelse af visse methanbisphosphonsyrederivater til at hindre løsning og vandring af proteser
AU3254395A (en) Use of a combination product that contains a competitive progesterone antagonist and a gestagen for the production of a pharmaceutical agent for treating endometriosis or leiomyomata uteri
NO994275L (no) Nikotinsyrepreparater til behandling av hyperlipidemi og tilknyttede fremgangsmaater
FI972434A0 (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: N.V. ORGANON, NL

Free format text: FORMER OWNER(S): AKZO NOBEL N.V., NL

MM4A Lapse of definitive patent protection due to non-payment of fees